BE840193A - Agents a base de polypeptides pour le blocage des reactions allergiques chez l'etre humain - Google Patents

Agents a base de polypeptides pour le blocage des reactions allergiques chez l'etre humain

Info

Publication number
BE840193A
BE840193A BE165690A BE165690A BE840193A BE 840193 A BE840193 A BE 840193A BE 165690 A BE165690 A BE 165690A BE 165690 A BE165690 A BE 165690A BE 840193 A BE840193 A BE 840193A
Authority
BE
Belgium
Prior art keywords
polypeptides
humans
allergic reactions
based agents
blocking allergic
Prior art date
Application number
BE165690A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE840193A publication Critical patent/BE840193A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0819Tripeptides with the first amino acid being acidic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
BE165690A 1975-04-04 1976-03-30 Agents a base de polypeptides pour le blocage des reactions allergiques chez l'etre humain BE840193A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56542575A 1975-04-04 1975-04-04

Publications (1)

Publication Number Publication Date
BE840193A true BE840193A (fr) 1976-09-30

Family

ID=24258538

Family Applications (1)

Application Number Title Priority Date Filing Date
BE165690A BE840193A (fr) 1975-04-04 1976-03-30 Agents a base de polypeptides pour le blocage des reactions allergiques chez l'etre humain

Country Status (4)

Country Link
US (1) US4161522A (xx)
JP (1) JPS602318B2 (xx)
BE (1) BE840193A (xx)
DE (1) DE2602443A1 (xx)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356119A (en) * 1978-09-28 1982-10-26 Nordisk Insulinlaboratorium Therapeutically active polypeptides or acid addition salts and a process for producing such compounds
DE2846412A1 (de) * 1978-10-25 1980-05-08 Behringwerke Ag Mittel zur behandlung allergischer reaktionen
US4396606A (en) * 1979-11-05 1983-08-02 Addiction Research Foundation Novel polypeptide analgesics
US4290944A (en) * 1980-07-31 1981-09-22 Northwestern University Antigenic peptide compound
US4529543A (en) * 1981-02-24 1985-07-16 Newport Pharmaceuticals International Hepatosin
DE3173568D1 (en) * 1981-09-21 1986-03-06 Univ Northwestern Antigenic peptide compound
US4472305A (en) * 1983-05-17 1984-09-18 Sterling Drug Inc. Hexapeptide amides
US4816449A (en) * 1984-08-09 1989-03-28 Immunetech Pharmaceuticals Immunotherapeutic anti-inflammatory peptide agents
US4683292A (en) * 1983-08-12 1987-07-28 Immunetech, Inc. Immunotherapeutic polypeptide agents which bind to lymphocyte immunoglobulin FC receptors
US4579840A (en) * 1983-08-12 1986-04-01 Immunetech Pharmaceuticals Method of blocking immune complex binding to immunoglobulin Fc receptors
US4686282A (en) * 1983-08-12 1987-08-11 Immunetech, Inc. Immunotherapeutic polypeptide agents which block immune complex binding to immunoglobulin Fc receptors
US5110795A (en) * 1984-08-09 1992-05-05 Immunetech Pharmaceuticals Methods and compositions for the treatment of inflammatory bowel diseases and conditions
US4753927A (en) * 1983-08-12 1988-06-28 Immunetech Pharmaceuticals Method of blocking immune complex binding to immunoglobulin Fc receptors
US5468730A (en) * 1984-08-09 1995-11-21 Dura Pharmaceuticals, Inc. Methods for the treatment of non-IgE-mediated diseases
ZA846192B (en) * 1984-08-09 1986-03-26 Merck Patent Gmbh Immunotherapeutic polypeptide agents
FR2598422B1 (fr) * 1986-05-09 1989-12-08 Centre Nat Rech Scient Pseudo-peptide comportant au moins la sequence de l'acide g-glutamyl-aspartique ou l'un de ses derives, son utilisation dans la preparation d'une composition pharmaceutique et composition pharmaceutique en resultant
US5180805A (en) * 1986-07-02 1993-01-19 Research Corporation Limited Polypeptide competitor for immunoglobulin E
GB8616166D0 (en) * 1986-07-02 1986-08-06 Research Corp Ltd Polypeptide competitor
JPS63225397A (ja) * 1986-10-03 1988-09-20 Dainippon Pharmaceut Co Ltd 抗アレルギー作用を有する新規ペプチド
US5231026A (en) * 1987-12-31 1993-07-27 Tanox Biosystems, Inc. DNA encoding murine-human chimeric antibodies specific for antigenic epitopes of IgE present on the extracellular segment of the membrane domain of membrane-bound IgE
US5422258A (en) * 1987-12-31 1995-06-06 Tanox Biosystems, Inc. Methods for producing high affinity anti-human IgE-monoclonal antibodies which binds to IgE on IgEabearing B cells but not basophils
US5252467A (en) * 1987-12-31 1993-10-12 Tanox Biosystems, Inc. Method of making antibodies to antigenic epitopes of IGE present on B cells but not basophil cell surface or secreted, soluble IGE
US5449760A (en) * 1987-12-31 1995-09-12 Tanox Biosystems, Inc. Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils
US5091313A (en) * 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
AU3184389A (en) * 1988-02-16 1989-09-06 Immunetech Pharmaceuticals Methods for treating immunoinflammatory and other disease conditions
JPH0742313B2 (ja) * 1988-03-28 1995-05-10 日立化成工業株式会社 新規ペプチド、その塩及びペプチド性抗アレルギー剤
US5292867A (en) * 1988-11-16 1994-03-08 Tanox Biosystems, Inc. Chimeric monoclonal antibodies which bind to the extracellular segment of the membrane-bound domain of a human membrane-bound immunoglobulin
US5212287A (en) * 1988-12-21 1993-05-18 Immunetech Pharmaceuticals, Inc. Pentapeptide synthesis
GB8905606D0 (en) * 1989-03-11 1989-04-26 Scras Peptides
US5252464A (en) * 1989-03-14 1993-10-12 Carlsberg Biotechnology Ltd. A/S Process for producing pentapeptides and intermediates for use in the synthesis
DK122489D0 (da) * 1989-03-14 1989-03-14 Carlsberg Biotechnology Ltd Fremgangsmaade til fremstilling af pentapeptider samt mellemprodukter til brug ved fremstillingen
US5955076A (en) * 1989-06-15 1999-09-21 Peptide Therapeutics Limited Immunoactive peptides and antibodies and their use in anti-allergy treatment
GB8913737D0 (en) * 1989-06-15 1989-08-02 Univ Birmingham A novel anti-allergy treatment
US5118669A (en) * 1989-09-20 1992-06-02 Hitachi Chemical Co., Ltd. Peptides and intermediates therefor useful as antiallergic agents, vasodilators and immunoregulators
US5223487A (en) * 1989-09-30 1993-06-29 Hitachi Chemical Co., Ltd. Peptides as antiallergic agents
US5965709A (en) * 1991-08-14 1999-10-12 Genentech, Inc. IgE antagonists
EP0627925B1 (en) * 1992-01-30 2004-09-29 Dendreon Corporation Trypsin inhibitors
US5534498A (en) * 1992-01-30 1996-07-09 Corvas International, Inc. Trypsin inhibitors
US5371072A (en) * 1992-10-16 1994-12-06 Corvas International, Inc. Asp-Pro-Arg α-keto-amide enzyme inhibitors
ATE276272T1 (de) * 1993-06-18 2004-10-15 Curative Tech Inc Entzündungshemmende peptide
US5561146A (en) * 1994-06-10 1996-10-01 Bristol-Myers Squibb Company Modified guanidino and amidino thrombin inhibitors
US7404967B2 (en) 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
RU2193413C2 (ru) 1996-03-01 2002-11-27 Новартис Аг Пептидные иммуногены для вакцинации и лечения аллергии
WO1999043301A1 (en) * 1998-02-24 1999-09-02 The Board Of Trustees Of The University Of Illinois Lipid emulsions in the treatment of systemic poisoning
US9688722B2 (en) * 2012-05-04 2017-06-27 The Board Of Regents Of The University Of Oklahoma Substrates and inhibitors of prolyl oligopeptidase and methods of use
EP3143036B1 (en) * 2014-05-11 2023-08-02 Tel Hashomer Medical Research Infrastructure and Services Ltd. Par-1 based therapeutic conjugates and uses thereof
WO2018129345A1 (en) 2017-01-08 2018-07-12 Resq Pharma, Inc. Methods for decreasing injuries associated with intraoperative hypotension
IL278311B2 (en) 2018-05-02 2024-02-01 Tel Hashomer Medical Res Infrastructure & Services Ltd Preparations and methods for the treatment of glioblastoma

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH427841A (de) 1959-08-24 1967-01-15 Ciba Geigy Verfahren zur Herstellung von a-(w-Aminoalkyl)-a-aminoessigsäuregruppenhaltigen Peptiden
CH436327A (de) 1962-12-10 1967-05-31 Sandoz Ag Verfahren zur Herstellung eines neuen Polypeptids
US3466368A (en) * 1967-06-02 1969-09-09 Us Health Education & Welfare Cleavage of human gamma globulin by means of cyanogen bromide
GB1212533A (en) 1967-09-04 1970-11-18 Nat Res Dev Improvements relating to peptide synthesis
GB1259870A (en) 1968-04-16 1972-01-12 Sandoz Ltd Polypeptides
IL31992A (en) 1968-05-08 1973-07-30 American Cyanamid Co Synthetic thyrocalcitonins and a method for their preparation
DE1941511C2 (de) 1968-08-23 1982-11-18 CIBA-GEIGY AG, 4002 Basel Calcitonin-Analoga und ihre α-Desamino- und N↑α↑-Acylaminoderivate, diese Peptide enthaltende pharmazeutische Präparate, und synthetische Verfahren zu ihrer Herstellung sowie zur Herstellung von Calcitonin M
DE1950711A1 (de) 1968-10-15 1970-04-30 Ciba Geigy Neue Peptide und Verfahren zu ihrer Herstellung
NL165454C (nl) 1969-05-05 1981-04-15 Lilly Co Eli Werkwijze ter bereiding van peptiden.
DE1924802A1 (de) 1969-05-14 1970-11-19 Hoechst Ag Verfahren zur Herstellung argininhaltiger Peptiden
US3664994A (en) * 1969-06-30 1972-05-23 Upjohn Co Process for separating horse gamma globulin fractions by chromatography
US3597409A (en) * 1970-05-25 1971-08-03 American Cyanamid Co Process for recoverring immunoglobulin a and immunoglobulin m
US3778426A (en) * 1970-12-16 1973-12-11 Research Corp Therapeutically useful polypeptides
US3763135A (en) * 1971-11-08 1973-10-02 Baxter Laboratories Inc Gamma globulin production from cohn fraction iii using polyethylene glycol
BE791604A (fr) 1971-11-19 1973-05-17 Lilly Co Eli Polypeptides et procedes de preparation de ceux-ci

Also Published As

Publication number Publication date
JPS602318B2 (ja) 1985-01-21
JPS51118702A (en) 1976-10-18
DE2602443A1 (de) 1976-10-21
DE2602443C2 (xx) 1987-10-01
US4161522A (en) 1979-07-17

Similar Documents

Publication Publication Date Title
BE840193A (fr) Agents a base de polypeptides pour le blocage des reactions allergiques chez l'etre humain
BR7604005A (pt) Conjunto de valvula desviadora e valvula misturadora aperfeicoado
FR2300486A1 (fr) Structure de contacteur d'interface programmable
BE838938A (fr) Comprimes efferverscents d'edulcorants
FR2299968A1 (fr) Dispositif d'
RO69967A (ro) Compozitie catalitica folosita la obtinerea acizilor nesaturati
FR2317533A1 (fr) Servomoteur d'assistance
FR2334862A1 (fr) Servomoteur d'assistance
FR2335379A1 (fr) Servomoteur d'assistance
BE831056A (fr) Mecanisme de blocage d'aubes
FR2307643A1 (fr) Dispositif d'ebarbage de pieces faconnees
FR2305670A1 (fr) Robinet d'arret
FR2304410A1 (fr) Tourniquet d'arrosage
FR2275271A1 (fr) Soudures a base d'or
FR2321061A1 (fr) Servomoteur d'assistance
FR2298966A1 (fr) Dispositif d'eplucha
BE835561A (fr) Crochet d'accouplement
BE851816A (fr) Perles d'auxiliaires de detergence
FR2298855A1 (fr) Dispositif d'in
FR2302532A1 (fr) Dispositif d'ecartometrie
ATA187476A (de) Mischbatterie-umstellvorrichtung
FR2318135A1 (fr) Oxychloruration de l'ethylene
FR2326610A1 (fr) Cheville d'ancrage
FR2302232A1 (fr) Stoppeur d'aussiere
FR2319825A1 (fr) Dispositif d'etanchement

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

Effective date: 19960330